Vascular Disrupting Agents (VDAs) represent a distinct class of antivascular cancer therapies engineered to selectively target and destroy existing tumor vasculature, leading to acute ischemia and tumor necrosis. Unlike anti-angiogenic agents that prevent new blood vessel formation, VDAs cause rapid collapse of established tumor blood vessels, offering synergistic potential when combined with...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt